- Global Pharma News & Resources

Katherine Relle Joins Accelmed as Vice President

Former J.P. Morgan Private Equity Portfolio Manager Marks Latest Addition to Accelmed’s Growing Team of HealthTech Investment Professionals

MIAMI--(BUSINESS WIRE)--Accelmed Partners (“Accelmed”), a private equity firm focused on acquiring and investing in U.S. commercial stage, lower middle market HealthTech companies, today announced that Katherine Relle has joined the firm as Vice President. Ms. Relle joins Accelmed from J.P. Morgan’s Private Equity Group, where she served as a Portfolio Manager and Vice President.

“Katherine is a seasoned and rising investment professional, who brings a tremendous amount of private equity investment experience to the firm and furthers our ability to source, identify and execute investments in HealthTech companies across the U.S.,” said Dr. Uri Geiger, Founder and Managing Partner of Accelmed.

Ms. Relle began her career at J.P. Morgan Private Banking, serving various roles across JPM’s Asset Management and Corporate Strategy teams. As Portfolio Manager within the J.P. Morgan Private Equity Group, Ms. Relle sat on the investment committee and helped oversee approximately $28 billion in investments. She also co-chaired both the Women On the Move Diversity & Inclusion Program and NextGen, J.P. Morgan’s 50,000-person employee mentoring program, where she worked directly with the bank’s operating committee, including CEO Jamie Dimon. Ms. Relle holds a B.A., magna cum laude, from Georgetown University, a M.Sc. from the London School of Economics, and an M.B.A. from Columbia Business School.

Ms. Relle is a rising industry leader, having been included in Forbes 30 Under 30 and InvestmentNews 40 Under 40, among others. In 2020, Ms. Relle was named Female Employee of the Year by J.P. Morgan Chase & Co.

“I’ve been extremely impressed with what Uri and the team have been able to accomplish in building Accelmed’s exceptional investment portfolio,” commented Ms. Relle. “With ample innovation thriving across HealthTech, I am tremendously excited to be joining Accelmed’s growing team and look forward to building the firm’s success and creating meaningful value in companies with strong growth potential.”

The addition of Ms. Relle comes as Accelmed continues to expand its team of investment professionals and network of industry partners. In June, the firm announced the addition of seasoned HealthTech Executive Eric Tansky as General Partner, and the addition of Stephen Rubin as Partner. Accelmed also announced the additions of accomplished executives Lewis Pell and Stanley Stern to its Executives Network.

“The ongoing evolution across the broader U.S. HealthTech space has created a significant demand for experienced investment partners who can guide founders and management teams through the execution of important growth initiatives,” added Dr. Geiger. “We are excited to add Katherine to our growing team and look forward to continuing to announce new additions at all levels.”

About Accelmed Partners

Accelmed is a U.S.-based private equity firm focused on acquiring and investing in U.S. commercial stage, lower middle market HealthTech companies. Since 2009, Accelmed has deployed over $400 million into companies spanning medical devices, diagnostics, digital health and technology-enabled healthcare services. Accelmed seeks to accelerate value and scale innovation across the HealthTech field by bringing to bear the team’s industry experience, operational and financial expertise, and strong global relationships. For more information, please visit


Amanda Klein/Alex Jeffrey
Gasthalter & Co.
(212) 257-4170

Editor Details

  • Company:
    • Businesswire
Last Updated: 14-Sep-2021